ArticleJournal of neurochemistry2025
Multiplexing FSCV and iGluSnFR3 Sensors Reveals Adenosine Transiently Inhibits Stimulated Dopamine and Glutamate Release.
Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multiplexed neurochemical monitoring reveals glutamate modulates dopamine neurotransmission in the nucleus accumbens.Neurochemistry international · 2026Article
- Multiplexing FSCV and iGluSnFR3 Sensors Reveals Adenosine Transiently Inhibits Stimulated Dopamine and Glutamate Release.Journal of neurochemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Simultaneous measurements of different neurotransmitters are challenging, but necessary, to understand neurotransmitter interactions in the brain. Genetically encoded sensors have a high spatial resolution, but there are still limited colors, while electrochemistry provides high time resolution but only for a limited number of electroactive analytes. Here, we multiplexed fast-scan cyclic voltammetry (FSCV) and genetically encoded fluorescence sensors to simultaneously measure adenosine, dopamine, and glutamate to investigate the spatial and temporal profiles of adenosine neuromodulation. A genetically encoded glutamate sensor (iGluSnFR3.v857) was expressed in the caudate-putamen region and then in a brain slice, a carbon fiber microelectrode (CFME) was implanted to monitor electrically stimulated dopamine release near cells expressing the glutamate sensor. Glutamate and dopamine release were inversely correlated, with areas with high stimulated glutamate release displaying low stimulated dopamine release and vice versa. Exogenous adenosine was applied locally to the brain slice, lasting 30 s, resulting in a transient inhibitory effect on both electrically stimulated dopamine and glutamate release. Inhibition by adenosine was observed only within a 250 μm distance, showing regional inhibition effects. Dopamine and glutamate release recovered 10 min after adenosine injection. The A
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.